Warberg Asset Management’s Catheter Precision VTAK Stock Holding History
Bought
Maintained
Sold
Other funds holding VTAK
HF
GSC
TRCT
SS
Warberg Asset Management's VTAK Position: Q2 2025 in Review
Warberg Asset Management sold out of Catheter Precision (VTAK) in Q2 2025, closing a stake of 9,479 shares — an estimated $62K sold.
Warberg Asset Management first reported a position in VTAK in Q3 2024 and held it in 3 quarters. The position peaked at $140K in Q4 2024. 12 funds tracked by Wall St. Rank hold VTAK as of Q2 2025.
- Warberg Asset Management reported no remaining Catheter Precision position as of Q2 2025 after selling out during the quarter.
- Warberg Asset Management sold 9,479 Catheter Precision shares in Q2 2025, an estimated $62K.
- Warberg Asset Management first reported a position in Catheter Precision in Q3 2024 and held it in 3 quarters.
- Warberg Asset Management's Catheter Precision position peaked at $140K in Q4 2024.
- 12 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2025.
Based on Warberg Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.